Literature DB >> 2760222

Use of mouse anti-rabies monoclonal antibodies in postexposure treatment of rabies.

C L Schumacher1, B Dietzschold, H C Ertl, H S Niu, C E Rupprecht, H Koprowski.   

Abstract

Immunization of mice and hamsters with a cocktail of mouse MAbs specific for rabies virus nucleocapsid protein and glycoprotein protected animals not only when challenged with a lethal dose of rabies virus after immunization, but also in post-exposure situations. Hamsters treated with the MAb cocktail 3 h after virus inoculation were completely protected from lethal rabies virus infection, and 80% of the animals survived when the MAb cocktail was given 36 h after virus challenge. The potential usefulness of this MAb cocktail for the postexposure treatment of human rabies is discussed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2760222      PMCID: PMC329743          DOI: 10.1172/JCI114260

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  17 in total

1.  Use of hyperimmune anti-rabies serum concentrates in experimental rabies.

Authors:  H KOPROWSKI; J VAN DER SCHEER; J BLACK
Journal:  Am J Med       Date:  1950-04       Impact factor: 4.965

2.  Failure of rabies postexposure treatment in Thailand.

Authors:  H Wilde; P Choomkasien; T Hemachudha; C Supich; S Chutivongse
Journal:  Vaccine       Date:  1989-02       Impact factor: 3.641

3.  Laboratory techniques in rabies. Habel test for potency.

Authors:  K Habel
Journal:  Monogr Ser World Health Organ       Date:  1966

4.  Induction and biological properties of defective interfering particles of rabies virus.

Authors:  T J Wiktor; B Dietzschold; R N Leamnson; H Koprowski
Journal:  J Virol       Date:  1977-02       Impact factor: 5.103

5.  Cellular origin and interactions involved in gamma-interferon production induced by OKt3 monoclonal antibody.

Authors:  T W Chang; D Testa; P C Kung; L Perry; H J Dreskin; G Goldstein
Journal:  J Immunol       Date:  1982-02       Impact factor: 5.422

6.  Phase-I clinical trial of monoclonal antibody in treatment of gastrointestinal tumours.

Authors:  H F Sears; B Atkinson; J Mattis; C Ernst; D Herlyn; Z Steplewski; P Häyry; H Koprowski
Journal:  Lancet       Date:  1982-04-03       Impact factor: 79.321

7.  Effects of monoclonal antibody immunotherapy on patients with gastrointestinal adenocarcinoma.

Authors:  H F Sears; D Herlyn; Z Steplewski; H Koprowski
Journal:  J Biol Response Mod       Date:  1984

8.  Murine cell surface glycoproteins. Identification, purification, and characterization of a major glycosylated component of 110,000 daltons by use of a monoclonal antibody.

Authors:  E N Hughes; J T August
Journal:  J Biol Chem       Date:  1982-04-10       Impact factor: 5.157

9.  Immunoglobulin (IgG) and (IgM) antibody responses to rabies vaccine.

Authors:  G S Turner
Journal:  J Gen Virol       Date:  1978-09       Impact factor: 3.891

10.  Monoclonal antibodies against rabies virus produced by somatic cell hybridization: detection of antigenic variants.

Authors:  T J Wiktor; H Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

View more
  20 in total

1.  Novel human monoclonal antibody combination effectively neutralizing natural rabies virus variants and individual in vitro escape mutants.

Authors:  Alexander B H Bakker; Wilfred E Marissen; R Arjen Kramer; Amy B Rice; William C Weldon; Michael Niezgoda; Cathleen A Hanlon; Sandra Thijsse; Harold H J Backus; John de Kruif; Bernhard Dietzschold; Charles E Rupprecht; Jaap Goudsmit
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

2.  Novel rabies virus-neutralizing epitope recognized by human monoclonal antibody: fine mapping and escape mutant analysis.

Authors:  Wilfred E Marissen; R Arjen Kramer; Amy Rice; William C Weldon; Michael Niezgoda; Milosz Faber; Jerry W Slootstra; Rob H Meloen; Marieke Clijsters-van der Horst; Therese J Visser; Mandy Jongeneelen; Sandra Thijsse; Mark Throsby; John de Kruif; Charles E Rupprecht; Bernhard Dietzschold; Jaap Goudsmit; Alexander B H Bakker
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

3.  Establishment of a longitudinal pre-clinical model of lyssavirus infection.

Authors:  Kate E Mastraccio; Celeste Huaman; David Warrilow; Greg A Smith; Scott B Craig; Dawn L Weir; Eric D Laing; Ina L Smith; Christopher C Broder; Brian C Schaefer
Journal:  J Virol Methods       Date:  2020-05-12       Impact factor: 2.014

Review 4.  Antibody-mediated clearance of viruses from the mammalian central nervous system.

Authors:  B Dietzschold
Journal:  Trends Microbiol       Date:  1993-05       Impact factor: 17.079

5.  Direct entry of rabies virus into the central nervous system without prior local replication.

Authors:  V Shankar; B Dietzschold; H Koprowski
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

6.  Effect of passive immunization or maternally transferred immunity on the antibody response to a genetic vaccine to rabies virus.

Authors:  Y Wang; Z Xiang; S Pasquini; H C Ertl
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

7.  Postexposure treatment with the live-attenuated rabies virus (RV) vaccine TriGAS triggers the clearance of wild-type RV from the Central Nervous System (CNS) through the rapid induction of genes relevant to adaptive immunity in CNS tissues.

Authors:  Jianwei Li; Adam Ertel; Carla Portocarrero; Darryll A Barkhouse; Bernhard Dietzschold; D Craig Hooper; Milosz Faber
Journal:  J Virol       Date:  2012-01-11       Impact factor: 5.103

8.  T and B cell human responses to European bat lyssavirus after post-exposure rabies vaccination.

Authors:  M Herzog; C Fritzell; M Lafage; J A Montaño Hirose; D Scott-Algara; M Lafon
Journal:  Clin Exp Immunol       Date:  1991-08       Impact factor: 4.330

9.  Novel vaccines to human rabies.

Authors:  Hildegund C J Ertl
Journal:  PLoS Negl Trop Dis       Date:  2009-09-29

10.  Development of a mouse monoclonal antibody cocktail for post-exposure rabies prophylaxis in humans.

Authors:  Thomas Müller; Bernhard Dietzschold; Hildegund Ertl; Anthony R Fooks; Conrad Freuling; Christine Fehlner-Gardiner; Jeannette Kliemt; Francois X Meslin; Richard Franka; Charles E Rupprecht; Noël Tordo; Alexander I Wanderler; Marie Paule Kieny
Journal:  PLoS Negl Trop Dis       Date:  2009-11-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.